Large spectrum of HLA-C recognition by killer Ig-like receptor (KIR)2DL2 and KIR2DL3 and restricted C1 specificity of KIR2DS2: Dominant impact of KIR2DL2/KIR2DS2 on KIR2D NK cell repertoire formation

Journal of Immunology

Volumn 191, Issue 9, 2013, Pages 4778-4788

  David, Gaëlle ^a   Djaoud, Zakia ^a   Willem, Catherine ^a   Legrand, Nolwenn ^a   Rettman, Pauline ^a   Gagne, Katia ^a,b,c   Cesbron, Anne ^a,b,c   Retière, Christelle ^a  

^a UNIVERSITÉ DE NANTES   (France)

^b ETABLISSEMENT FRANÇAIS DU SANG   (France)

^c UNIVERSITÉ DE STRASBOURG   (France)

Author keywords

[No Author keywords available]

Indexed keywords

HLA C ANTIGEN; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 2DL2; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 2DL3; KIR2DS2 RECEPTOR; LYMPHOCYTE RECEPTOR; UNCLASSIFIED DRUG; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 2DL1; KIR2DL1 PROTEIN, HUMAN; KIR2DL2 PROTEIN, HUMAN; KIR2DL3 PROTEIN, HUMAN; KIR2DS2 PROTEIN, HUMAN;

ALLELE; ALLOIMMUNITY; ANTIGEN RECOGNITION; ANTIGEN SPECIFICITY; ARTICLE; BIOCHEMICAL COMPOSITION; CELL CLONE; CELL COMPARTMENTALIZATION; CONTROLLED STUDY; DEGRANULATION; GENE EXPRESSION; GENOTYPE; HUMAN; HUMAN CELL; INHIBITION KINETICS; KIR2DS1 GENE; KIR2DS2 GENE; LYMPHOCYTE ACTIVATION; NATURAL KILLER CELL; PHENOTYPE; PRIORITY JOURNAL; RECEPTOR GENE; CELL CULTURE; GENETICS; IMMUNOLOGY; METABOLISM;

ALLELES; CELLS, CULTURED; GENOTYPE; HLA-C ANTIGENS; HUMANS; KILLER CELLS, NATURAL; LYMPHOCYTE ACTIVATION; RECEPTORS, KIR; RECEPTORS, KIR2DL1; RECEPTORS, KIR2DL2; RECEPTORS, KIR2DL3;

EID: 84886045832     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1301580     Document Type: Article

References (37)

1. Kärre, K. 2002. NK cells, MHC class I molecules and the missing self. Scand. J. Immunol. 55: 221-228.
2. Ruggeri, L., M. Capanni, M. Casucci, I. Volpi, A. Tosti, K. Perruccio, E. Urbani, R. S. Negrin, M. F. Martelli, and A. Velardi. 1999. Role of natural killer cell alloreactivity in HLA-mismatched hematopoietic stem cell transplantation. Blood 94: 333-339.
3. Ruggeri, L., M. Capanni, E. Urbani, K. Perruccio, W. D. Shlomchik, A. Tosti, S. Posati, D. Rogaia, F. Frassoni, F. Aversa, et al. 2002. Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants. Science 295: 2097-2100.
4. Sivori, S., C. Cantoni, S. Parolini, E. Marcenaro, R. Conte, L. Moretta, and A. Moretta. 2003. IL-21 induces both rapid maturation of human CD34+ cell precursors towards NK cells and acquisition of surface killer Ig-like receptors. Eur. J. Immunol. 33: 3439-3447.
5. Santourlidis, S., H.-I. Trompeter, S. Weinhold, B. Eisermann, K. L. Meyer, P. Wernet, and M. Uhrberg. 2002. Crucial role of DNA methylation in determination of clonally distributed killer cell Ig-like receptor expression patterns in NK cells. J. Immunol. 169: 4253-4261.
6. Uhrberg, M., N. M. Valiante, B. P. Shum, H. G. Shilling, K. Lienert-Weidenbach, B. Corliss, D. Tyan, L. L. Lanier, and P. Parham. 1997. Human diversity in killer cell inhibitory receptor genes. Immunity 7: 753-763.
7. Anfossi, N., P. André, S. Guia, C. S. Falk, S. Roetynck, C. A. Stewart, V. Breso, C. Frassati, D. Reviron, D. Middleton, et al. 2006. Human NK cell education by inhibitory receptors for MHC class I. Immunity 25: 331-342.
8. Béziat, V., J. A. Traherne, L. L. Liu, J. Jayaraman, M. Enqvist, S. Larsson, J. Trowsdale, and K.-J. Malmberg. 2013. Influence of KIR gene copy number on natural killer cell education. Blood 121: 4703-4707.
9. Schönberg, K., M. Sribar, J. Enczmann, J. C. Fischer, and M. Uhrberg. 2011. Analyses of HLA-C-specific KIR repertoires in donors with group A and B haplotypes suggest a ligand-instructed model of NK cell receptor acquisition. Blood 117: 98-107.
10. Andersson, S., C. Fauriat, J.-A. Malmberg, H.-G. Ljunggren, and K.-J. Malmberg. 2009. KIR acquisition probabilities are independent of self-HLA class I ligands and increase with cellular KIR expression. Blood 114: 95-104.
11. Mandelboim, O., H. T. Reyburn, M. Valés-Gómez, L. Pazmany, M. Colonna, G. Borsellino, and J. L. Strominger. 1996. Protection from lysis by natural killer cells of group 1 and 2 specificity is mediated by residue 80 in human histocompatibility leukocyte antigen C alleles and also occurs with empty major histocompatibility complex molecules. J. Exp. Med. 184: 913-922.
12. Moesta, A. K., P. J. Norman, M. Yawata, N. Yawata, M. Gleimer, and P. Parham. 2008. Synergistic polymorphism at two positions distal to the ligand-binding site makes KIR2DL2 a stronger receptor for HLA-C than KIR2DL3. J. Immunol. 180: 3969-3979.
13. Winter, C. C., J. E. Gumperz, P. Parham, E. O. Long, and N. Wagtmann. 1998. Direct binding and functional transfer of NK cell inhibitory receptors reveal novel patterns of HLA-C allotype recognition. J. Immunol. 161: 571-577.
14. Chewning, J. H., C. N. Gudme, K. C. Hsu, A. Selvakumar, and B. Dupont. 2007. KIR2DS1-positive NK cells mediate alloresponse against the C2 HLA-KIR ligand group in vitro. J. Immunol. 179: 854-868.
15. Morvan, M., G. David, V. Sébille, A. Perrin, K. Gagne, C. Willem, N. Kerdudou, L. Denis, B. Clémenceau, G. Folléa, et al. 2008. Autologous and allogeneic HLA KIR ligand environments and activating KIR control KIR NK-cell functions. Eur. J. Immunol. 38: 3474-3486.
16. VandenBussche, C. J., T. J. Mulrooney, W. R. Frazier, S. Dakshanamurthy, and C. K. Hurley. 2009. Dramatically reduced surface expression of NK cell receptor KIR2DS3 is attributed to multiple residues throughout the molecule. Genes Immun. 10: 162-173.
17. Gendzekhadze, K., P. J. Norman, L. Abi-Rached, T. Graef, A. K. Moesta, Z. Layrisse, and P. Parham. 2009. Co-evolution of KIR2DL3 with HLA-C in a human population retaining minimal essential diversity of KIR and HLA class I ligands. Proc. Natl. Acad. Sci. USA 106: 18692-18697.
18. Morvan, M., C. Willem, K. Gagne, N. Kerdudou, G. David, V. Sébille, G. Folléa, J.-D. Bignon, and C. Retière. 2009. Phenotypic and functional analyses of KIR3DL1+ and KIR3DS1+ NK cell subsets demonstrate differential regulation by Bw4 molecules and induced KIR3DS1 expression on stimulated NK cells. J. Immunol. 182: 6727-6735.
19. Thompson, A., A. R. van der Slik, F. Koning, and J. van Bergen. 2006. An improved RT-PCR method for the detection of killer-cell immunoglobulin-like receptor (KIR) transcripts. Immunogenetics 58: 865-872.
20. David, G., M. Morvan, K. Gagne, N. Kerdudou, C. Willem, A. Devys, M. Bonneville, G. Folléa, J.-D. Bignon, and C. Retière. 2009. Discrimination between the main activating and inhibitory killer cell immunoglobulin-like receptor positive natural killer cell subsets using newly characterized monoclonal antibodies. Immunology 128: 172-184.
21. Middleton, D., A. Meenagh, and P. A. Gourraud. 2007. KIR haplotype content at the allele level in 77 Northern Irish families. Immunogenetics 59: 145-158.
22. Hilton, H. G., L. Vago, A. M. Older Aguilar, A. K. Moesta, T. Graef, L. AbiRached, P. J. Norman, L. A. Guethlein, K. Fleischhauer, and P. Parham. 2012. Mutation at positively selected positions in the binding site for HLA-C shows that KIR2DL1 is a more refined but less adaptable NK cell receptor than KIR2DL3. J. Immunol. 189: 1418-1430.
23. Boyington, J. C., A. G. Brooks, and P. D. Sun. 2001. Structure of killer cell immunoglobulin-like receptors and their recognition of the class I MHC molecules. Immunol. Rev. 181: 66-78.
24. Fischer, J. C., H. Ottinger, S. Ferencik, M. Sribar, M. Punzel, D. W. Beelen, M. A. Schwan, H. Grosse-Wilde, P. Wernet, and M. Uhrberg. 2007. Relevance of C1 and C2 epitopes for hemopoietic stem cell transplantation: role for sequential acquisition of HLA-C-specific inhibitory killer Ig-like receptor. J. Immunol. 178: 3918-3923.
25. Maenaka, K., T. Juji, D. I. Stuart, and E. Y. Jones. 1999. Crystal structure of the human p58 killer cell inhibitory receptor (KIR2DL3) specific for HLA-Cw3related MHC class I. Structure 7: 391-398.
26. Maenaka, K., T. Juji, T. Nakayama, J. R. Wyer, G. F. Gao, T. Maenaka, N. R. Zaccai, A. Kikuchi, T. Yabe, K. Tokunaga, et al 1999. Killer cell immunoglobulin receptors and T cell receptors bind peptide-major histocompatibility complex class I with distinct thermodynamic and kinetic properties. J. Biol. Chem. 274: 28329-28334.
27. Moesta, A. K., and P. Parham. 2012. Diverse functionality among human NK cell receptors for the C1 epitope of HLA-C: KIR2DS2, KIR2DL2, and KIR2DL3. Front. Immunol. 3: 336.
28. Pende, D., S. Marcenaro, M. Falco, S. Martini, M. E. Bernardo, D. Montagna, E. Romeo, C. Cognet, M. Martinetti, R. Maccario, et al. 2009. Anti-leukemia activity of alloreactive NK cells in KIR ligand-mismatched haploidentical HSCT for pediatric patients: evaluation of the functional role of activating KIR and redefinition of inhibitory KIR specificity. Blood 113: 3119-3129.
29. + NK cells in cytomegalovirus (CMV) infection preferentially express killer cell Ig-like receptor 2DL: Functional impact in controlling CMVinfected dendritic cells. J. Immunol. 191: 2708-2716.
30. Saulquin, X., L. N. Gastinel, and E. Vivier. 2003. Crystal structure of the human natural killer cell activating receptor KIR2DS2 (CD158j). J. Exp. Med. 197: 933-938.
31. Hiby, S. E., J. J. Walker, K. M. O'shaughnessy, C. W. G. Redman, M. Carrington, J. Trowsdale, and A. Moffett. 2004. Combinations of maternal KIR and fetal HLA-C genes influence the risk of preeclampsia and reproductive success. J. Exp. Med. 200: 957-965.
32. Hiby, S. E., L. Regan, W. Lo, L. Farrell, M. Carrington, and A. Moffett. 2008. Association of maternal killer-cell immunoglobulin-like receptors and parental HLA-C genotypes with recurrent miscarriage. Hum. Reprod. 23: 972-976.
33. Khakoo, S. I., C. L. Thio, M. P. Martin, C. R. Brooks, X. Gao, J. Astemborski, J. Cheng, J. J. Goedert, D. Vlahov, M. Hilgartner, et al 2004. HLA and NK cell inhibitory receptor genes in resolving hepatitis C virus infection. Science 305: 872-874.
34. Borhis, G., P. S. Ahmed, B. Mbiribindi, M. M. Naiyer, D. M. Davis, M. A. Purbhoo, and S. I. Khakoo. 2013. A peptide antagonist disrupts NK cell inhibitory synapse formation. J. Immunol. 190: 2924-2930.
35. Miller, J. S., and V. McCullar. 2001. Human natural killer cells with polyclonal lectin and immunoglobulinlike receptors develop from single hematopoietic stem cells with preferential expression of NKG2A and KIR2DL2/L3/S2. Blood 98: 705-713.
36. Yawata, M., N. Yawata, M. Draghi, A.-M. Little, F. Partheniou, and P. Parham. 2006. Roles for HLA and KIR polymorphisms in natural killer cell repertoire selection and modulation of effector function. J. Exp. Med. 203: 633-645.
37. Gagne, K., C. Willem, N. Legrand, Z. Djaoud, G. David, P. Rettman, C. Bressollette-Bodin, D. Senitzer, J. Esbelin, A. Cesbron-Gautier, et al 2013. Both the nature of KIR3DL1 alleles and the KIR3DL1/S1 allele combination affect the KIR3DL1 NK-cell repertoire in the French population. Eur. J. Immunol. 43: 1085-1098.